Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001029142-25-000083
Filing Date
2025-05-13
Accepted
2025-05-13 16:06:42
Documents
3
Period of Report
2025-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1747166793.html 3  
1 FORM 3 wk-form3_1747166793.xml 3 1673
2 EX-24 dvax-formpowerofattorney.htm EX-24 3948
3 dvax-formpowerofattorney001.jpg GRAPHIC 216730
  Complete submission text file 0001029142-25-000083.txt   305708
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DYNAVAX TECHNOLOGIES CORPORATION 2100 POWELL STREET, SUITE 720 EMERYVILLE CA 94608
Business Address
Metzinger Joseph Anthony (Reporting) CIK: 0002067729 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 25940017